Rebecca Weil
Corporate Officer/Principal bij OCULIS HOLDING AG
Profiel
Rebecca Weil is currently the Chief Commercial Officer at Oculis Holding AG.
Prior to her current position, she held various roles including Director at Juvenile Diabetes Research Foundation (New York), Global Head-Marketing, Strategy & Pharmaceuticals at Bausch + Lomb Corp., and Head-Regional Franchise Asia, Middle East & Africa at Novartis AG.
From 2019 to 2023, she served as the Head-Global Marketing at Idorsia Ltd.
Before that, she was the Group Vice President & Head-Corporate Affairs at Shire Plc from 2018 to 2019.
Rebecca also worked as the Vice President & Head-Western Europe at Alcon AG.
She holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Actieve functies van Rebecca Weil
| Bedrijven | Functie | Begin |
|---|---|---|
| OCULIS HOLDING AG | Corporate Officer/Principal | 11-09-2023 |
Eerdere bekende functies van Rebecca Weil
| Bedrijven | Functie | Einde |
|---|---|---|
| IDORSIA LTD | Verkoop & Marketing | 01-08-2023 |
| SHIRE | Corporate Officer/Principal | 01-03-2019 |
| Juvenile Diabetes Research Foundation (New York) | Directeur/Bestuurslid | - |
| BAUSCH + LOMB CORPORATION | Verkoop & Marketing | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Opleiding van Rebecca Weil
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| OCULIS HOLDING AG | Health Technology |
| IDORSIA LTD | Health Technology |
| ALCON INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| BAUSCH + LOMB CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Juvenile Diabetes Research Foundation (New York) |
